Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
IPO Year: 2021
Exchange: NYSE
Fastest customizable press release news feed in the world
PHILADELPHIA, May 28, 2021 /PRNewswire/ -- Ibere Pharmaceuticals (NYSE:IBER) (the "Company") today announced that it received a notice on May 25, 2021 from the New York Stock Exchange (the "NYSE") indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the "Quarterly Report") with the Securities and Exchange Commission (the "SEC"). The notice has no immediate effect on the listing of the Company's stock on the NYSE. As disclosed in the Company's Form 12b-25 filed with the SEC on May 18, 2021, on April 12, 2021 the Staff of the SEC re
15-12G - IBERE PHARMACEUTICALS (0001835205) (Filer)
25-NSE - IBERE PHARMACEUTICALS (0001835205) (Subject)
8-K - IBERE PHARMACEUTICALS (0001835205) (Filer)
10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
10-K - IBERE PHARMACEUTICALS (0001835205) (Filer)
10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
10-Q/A - IBERE PHARMACEUTICALS (0001835205) (Filer)
10-Q - IBERE PHARMACEUTICALS (0001835205) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G/A - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)
SC 13G - IBERE PHARMACEUTICALS (0001835205) (Subject)